Journal of Clinical Virology
Volume 43, Issue 4 , Pages 396-400 , December 2008

The emergence of Nipah virus, a highly pathogenic paramyxovirus

  • Michael K. Lo

      Affiliations

    • Centers for Disease Control and Prevention, Measles, Mumps, Rubella, and Herpesviruses Laboratory Branch, 1600 Clifton Road, Mailstop C-22, Atlanta, GA 30333, United States
    • Emory University, Department of Microbiology and Immunology, 1510 Clifton Road, Atlanta, GA 30322, United States
    • ,
  • Paul A. Rota

      Affiliations

    • Centers for Disease Control and Prevention, Measles, Mumps, Rubella, and Herpesviruses Laboratory Branch, 1600 Clifton Road, Mailstop C-22, Atlanta, GA 30333, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 404 639 4181; fax: +1 404 639 4187.

Received 9 June 2008 ,Accepted 14 August 2008.

References 

  1. CDC . Outbreak of Hendra-like virus—Malaysia and Singapore, 1998–1999. Morbid Mortal Wkly Rep. 1999;48:265–269
  2. CDC . Update: outbreak of Nipah virus—Malaysia and Singapore, 1999. Morbid Mortal Wkly Rep. 1999;48:335–337
  3. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, et al. Nipah virus: a recently emergent deadly paramyxovirus. Science. 2000;288:1432–1435
  4. Parashar UD, Sunn LM, Ong F, Mounts AW, Arif MT, Ksiazek TG, et al. Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998–1999 outbreak of severe encephalitis in Malaysia. J Infect Dis. 2000;181:1755–1759
  5. Chua KB, Lam SK, Goh KJ, Hooi PS, Ksiazek TG, Kamarulzaman A, et al. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect. 2001;42:40–43
  6. Middleton DJ, Westbury HA, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, et al. Experimental Nipah virus infection in pigs and cats. J Comp Pathol. 2002;126:124–136
  7. Hsu VP, Hossain MJ, Parashar UD, Ali MM, Ksiazek TG, Kuzmin I, et al. Nipah virus encephalitis re-emergence, Bangladesh. Emerg Infect Dis. 2004;10:2082–2087
  8. ICDDRB . Nipah encephalitis outbreak over a wide area of Bangladesh. Hlth Sci Bull. 2004;2:7–11
  9. ICDDRB . Person-to-person transmission of Nipah virus during outbreak in Faridpur District. Hllth Sci Bull. 2004;2:5–9
  10. Luby SP, Rahman M, Hossain MJ, Blum LS, Husain MM, Gurley E, et al. Foodborne transmission of Nipah virus, Bangladesh. Emerg Infect Dis. 2006;12:1888–1894
  11. PROMED-MAIL. Nipah virus, fatal. Bangladesh; 2008.
  12. WHO . Nipah virus outbreak(s) in Bangladesh, January–April 2004. Wkly Epidemiol Rec. 2004;17:168–171
  13. Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, et al. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis. 2006;12:235–240
  14. Harit AK, Ichhpujani RL, Gupta S, Gill KS, Lal S, Ganguly NK, et al. Nipah/Hendra virus outbreak in Siliguri, West Bengal, India in 2001. Indian J Med Res. 2006;123:553–560
  15. PROMED-MAIL. Nipah virus, fatal. India (West Bengal); 2007.
  16. Hossain MJ, Gurley ES, Montgomery JM, Bell M, Carroll DS, Hsu VP, et al. Clinical presentation of Nipah virus infection in Bangladesh. Clin Infect Dis. 2008;46:977–984
  17. Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, Islam MR, et al. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis. 2007;13:1031–1037
  18. Gurley ES, Montgomery JM, Hossain MJ, Islam MR, Molla MA, Shamsuzzaman SM, et al. Risk of nosocomial transmission of Nipah virus in a Bangladesh hospital. Infect Control Hosp Epidemiol. 2007;28:740–742
  19. Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, et al. Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg Infect Dis. 2005;11:1594–1597
  20. Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000;342:1229–1235
  21. Tan CT, Goh KJ, Wong KT, Sarji SA, Chua KB, Chew NK, et al. Relapsed and late-onset Nipah encephalitis. Ann Neurol. 2002;51:703–708
  22. Bojinova VS, Dimova PS, Belopitova LD, Mihailov AS, Gatcheva NL, Mihneva ZG, et al. Clinical and epidemiological characteristics of subacute sclerosing panencephalitis in Bulgaria during the past 25 years (1978–2002). Eur J Paediatr Neurol. 2004;8:89–94
  23. Dubois B, Lemmens R, Laffut W, Van Ranst M. Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis. Neurology. 2005;65:1145–1146[author reply 1145–6]
  24. O’Sullivan JD, Allworth AM, Paterson DL, Snow TM, Boots R, Gleeson LJ, et al. Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet. 1997;349:93–95
  25. Ozturk A, Gurses C, Baykan B, Gokyigit A, Eraksoy M. Subacute sclerosing panencephalitis: clinical and magnetic resonance imaging evaluation of 36 patients. J Child Neurol. 2002;17:25–29
  26. Sener RN. Subacute sclerosing panencephalitis findings at MR imaging, diffusion MR imaging, and proton MR spectroscopy. AJNR Am J Neuroradiol. 2004;25:892–894
  27. Sejvar JJ, Hossain J, Saha SK, Gurley ES, Banu S, Hamadani JD, et al. Long-term neurological and functional outcome in Nipah virus infection. Ann Neurol. 2007;62:235–242
  28. Quddus R, Alam S, Majumdar MA, Anwar S, Khan MR, Zahid Mahmud Khan A, et al. A report of 4 patients with Nipah encephalitis from Rajbari district, Bangladesh in the January 2004 outbreak. Neurol Asia. 2004;9:33–37
  29. Mohd NMN, Gan CH, Ong BL. Nipah virus infection of pigs in peninsular Malaysia. Rev Sci Tech Off Int Epiz. 2000;19:160–165
  30. Halpin K, Young PL, Field HE, Mackenzie JS. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J Gen Virol. 2000;81:1927–1932
  31. Yob JM, Field H, Rashdi AM, Morrissy C, van der Heide B, Rota P, et al. Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia. Emerg Infect Dis. 2001;7:439–441
  32. Chua KB, Koh CL, Hooi PS, Wee KF, Khong JH, Chua BH, et al. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect. 2002;4:145–151
  33. Reynes JM, Counor D, Ong S, Faure C, Seng V, Molia S, et al. Nipah virus in Lyle’s flying foxes, Cambodia. Emerg Infect Dis. 2005;11:1042–1047
  34. Sendow I, Field HE, Curran J, Darminto , Morrissy C, Meehan G, et al. Henipavirus in Pteropus vampyrus Bats, Indonesia. Emerg Infect Dis. 2006;12:711–712
  35. Wacharapluesadee S, Lumlertdacha B, Boongird K, Wanghongsa S, Chanhome L, Rollin P, et al. Bat Nipah virus, Thailand. Emerg Infect Dis. 2005;11:1949–1951
  36. Pulliam JR, Field HE, Olival KJ. Nipah virus strain variation. Emerg Infect Dis. 2005;11:1978–1979[author reply 1979]
  37. Middleton DJ, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, Westbury HA, et al. Experimental Nipah virus infection in pteropid bats (Pteropus poliocephalus). J Comp Pathol. 2007;136:266–272
  38. Hall L, Richards G. Flying foxes: fruit and blossom bats of Australia. Sydney: University of New South Wales Press; 2000;p. 64
  39. Halpin K, Mungall BA. Recent progress in henipavirus research. Comp Immunol Microbiol Infect Dis. 2007;30:287–307
  40. Chan YP, Chua KB, Koh CL, Lim ME, Lam SK. Complete nucleotide sequences of Nipah virus isolates from Malaysia. J Gen Virol. 2001;82:2151–2155
  41. Harcourt BH, Tamin A, Halpin K, Ksiazek TG, Rollin PE, Bellini WJ, et al. Molecular characterization of the polymerase gene and genomic termini of Nipah virus. Virology. 2001;287:192–201
  42. Harcourt BH, Tamin A, Ksiazek TG, Rollin PE, Anderson LJ, Bellini WJ, et al. Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology. 2000;271:334–349
  43. Lo MK, Harcourt BH, Mungall BA, Rota P. Determination of henipavirus P gene mRNA editing frequency and detection of P, V, W, and C proteins in NiV-infected cells. CDC, CSIRO; in preparation.
  44. Rodriguez JJ, Cruz CD, Horvath CM. Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion. J Virol. 2004;78:5358–5367
  45. Rodriguez JJ, Parisien JP, Horvath CM. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol. 2002;76:11476–11483
  46. Shaw ML, Cardenas WB, Zamarin D, Palese P, Basler CF. Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways. J Virol. 2005;79:6078–6088
  47. Shaw ML, Garcia-Sastre A, Palese P, Basler CF. Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol. 2004;78:5633–5641
  48. Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci USA. 2005;102:10652–10657
  49. Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature. 2005;436:401–405
  50. Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, Muhlberger E, et al. Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog. 2006;2:e7
  51. Bergemann AD, Zhang L, Chiang MK, Brambilla R, Klein R, Flanagan JG. Ephrin-B3, a ligand for the receptor EphB3, expressed at the midline of the developing neural tube. Oncogene. 1998;16:471–480
  52. Flenniken AM, Gale NW, Yancopoulos GD, Wilkinson DG. Distinct and overlapping expression patterns of ligands for Eph-related receptor tyrosine kinases during mouse embryogenesis. Dev Biol. 1996;179:382–401
  53. Hooper P, Zaki S, Daniels P, Middleton D. Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes Infect. 2001;3:315–322
  54. Wong KT, Shieh WJ, Kumar S, Norain K, Abdullah W, Guarner J, et al. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol. 2002;161:2153–2167
  55. Bowden TA, Aricescu AR, Gilbert RJ, Grimes JM, Jones EY, Stuart DI. Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol. 2008;
  56. Yoneda M, Guillaume V, Ikeda F, Sakuma Y, Sato H, Wild TF, et al. Establishment of a Nipah virus rescue system. Proc Natl Acad Sci USA. 2006;103:16508–16513
  57. Daniels P, Ksiazek T, Eaton BT. Laboratory diagnosis of Nipah and Hendra virus infections. Microbes Infect. 2001;3:289–295
  58. Chow VT, Tambyah PA, Yeo WM, Phoon MC, Howe J. Diagnosis of Nipah virus encephalitis by electron microscopy of cerebrospinal fluid. J Clin Virol. 2000;19:143–147
  59. AbuBakar S, Chang LY, Ali AR, Sharifah SH, Yusoff K, Zamrod Z. Isolation and molecular identification of Nipah virus from pigs. Emerg Infect Dis. 2004;10:2228–2230
  60. Guillaume V, Lefeuvre A, Faure C, Marianneau P, Buckland R, Lam SK, et al. Specific detection of Nipah virus using real-time RT-PCR (TaqMan). J Virol Methods. 2004;120:229–237
  61. Wacharapluesadee S, Hemachudha T. Duplex nested RT-PCR for detection of Nipah virus RNA from urine specimens of bats. J Virol Methods. 2007;141:97–101
  62. Chen JM, Yu M, Morrissy C, Zhao YG, Meehan G, Sun YX, et al. A comparative indirect ELISA for the detection of henipavirus antibodies based on a recombinant nucleocapsid protein expressed in Escherichia coli. J Virol Methods. 2006;136:273–276
  63. Eshaghi M, Tan WS, Chin WK, Yusoff K. Purification of the extra-cellular domain of Nipah virus glycoprotein produced in Escherichia coli and possible application in diagnosis. J Biotechnol. 2005;116:221–226
  64. Eshaghi M, Tan WS, Mohidin TB, Yusoff K. Nipah virus glycoprotein: production in baculovirus and application in diagnosis. Virus Res. 2004;106:71–76
  65. Eshaghi M, Tan WS, Ong ST, Yusoff K. Purification and characterization of Nipah virus nucleocapsid protein produced in insect cells. J Clin Microbiol. 2005;43:3172–3177
  66. Juozapaitis M, Serva A, Zvirbliene A, Slibinskas R, Staniulis J, Sasnauskas K, et al. Generation of henipavirus nucleocapsid proteins in yeast Saccharomyces cerevisiae. Virus Res. 2007;124:95–102
  67. Kashiwazaki Y, Na YN, Tanimura N, Imada T. A solid-phase blocking ELISA for detection of antibodies to Nipah virus. J Virol Methods. 2004;121:259–261
  68. Tan WS, Ong ST, Eshaghi M, Foo SS, Yusoff K. Solubility, immunogenicity and physical properties of the nucleocapsid protein of Nipah virus produced in Escherichia coli. J Med Virol. 2004;73:105–112
  69. Tanimura N, Imada T, Kashiwazaki Y, Shahirudin S, Sharifah SH, Aziz AJ. Monoclonal antibody-based immunohistochemical diagnosis of Malaysian Nipah virus infection in pigs. J Comp Pathol. 2004;131:199–206
  70. Tanimura N, Imada T, Kashiwazaki Y, Shamusudin S, Syed Hassan S, Jamaluddin A, et al. Reactivity of anti-Nipah virus monoclonal antibodies to formalin-fixed, paraffin-embedded lung tissues from experimental Nipah and Hendra virus infections. J Vet Med Sci. 2004;66:1263–1266
  71. Yu F, Khairullah NS, Inoue S, Balasubramaniam V, Berendam SJ, Teh LK, et al. Serodiagnosis using recombinant Nipah virus nucleocapsid protein expressed in Escherichia coli. J Clin Microbiol. 2006;44:3134–3138
  72. Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, McEachern JA, et al. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. J Infect Dis. 2008;197:846–853
  73. Zhu Z, Dimitrov AS, Bossart KN, Crameri G, Bishop KA, Choudhry V, et al. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. J Virol. 2006;80:891–899
  74. Bossart KN, McEachern JA, Hickey AC, Choudhry V, Dimitrov DS, Eaton BT, et al. Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems. J Virol Methods. 2007;142:29–40
  75. Chen JM, Yaiw KC, Yu M, Wang LF, Wang QH, Crameri G, et al. Expression of truncated phosphoproteins of Nipah virus and Hendra virus in Escherichia coli for the differentiation of henipavirus infections. Biotechnol Lett. 2007;29:871–875
  76. Chong HT, Kamarulzaman A, Tan CT, Goh KJ, Thayaparan T, Kunjapan SR, et al. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol. 2001;49:810–813
  77. Georges-Courbot MC, Contamin H, Faure C, Loth P, Baize S, Leyssen P, et al. Poly(I)–poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection. Antimicrob Agents Chemother. 2006;50:1768–1772
  78. Bossart KN, Mungall BA, Crameri G, Wang LF, Eaton BT, Broder CC. Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein. Virol J. 2005;2:57
  79. Porotto M, Carta P, Deng Y, Kellogg GE, Whitt M, Lu M, et al. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors. J Virol. 2007;81:10567–10574
  80. Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, et al. Inhibition of hendra virus fusion. J Virol. 2006;80:9837–9849
  81. Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng YR, Patch JR, et al. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. J Virol. 2005;79:6690–6702
  82. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 1991;108:193–199

PII: S1386-6532(08)00292-8

doi: 10.1016/j.jcv.2008.08.007

Journal of Clinical Virology
Volume 43, Issue 4 , Pages 396-400 , December 2008

Article Tools

* Image Usage & Resolution